NHC executive granted 1,294 restricted shares

Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president of operations Timothy J. Shelly received an equity award of 1,294 shares of common stock on February 27, 2026. The award was granted at $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.

The granted shares are restricted and follow a three-year vesting schedule. One-third of the award is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029. The filing also lists existing stock options, showing post-transaction holdings of 2,400, 8,000, 11,000, and 14,000 options under various grants, all held directly.

Insider Trade Summary

Grant/Award: 1,294 shares

Grant/Award 5 txns

Insider Shelly Timothy J.

Role Sr.VP Operations

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,294	$0.00	$0.00
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,294 shares (Direct); Option to Purchase Common Stock — 35,400 contracts (Direct)

Footnotes (1)

1. F1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC executive Timothy J. Shelly report on this Form 4?

Timothy J. Shelly reported an acquisition of 1,294 shares of National Healthcare Corp common stock as a restricted stock grant. The shares were awarded at $0.00 per share, reflecting stock-based compensation rather than an open-market purchase.

How do the 1,294 restricted NHC shares for Timothy J. Shelly vest?

The 1,294 restricted shares vest in three equal installments over three years. 33 1/3% vest on January 1, 2027, another 33 1/3% on January 1, 2028, and the remaining 33 1/3% on January 1, 2029.

Did Timothy J. Shelly buy or sell NHC shares on the open market in this filing?

No open-market buy or sell is reported. The Form 4 shows a grant of 1,294 restricted shares at $0.00 per share, indicating stock-based compensation. It does not list any market purchases or sales of National Healthcare Corp stock.

What stock options for National Healthcare Corp does Timothy J. Shelly hold after this Form 4?

The filing lists several direct holdings of options to purchase common stock, with post-transaction balances of 2,400, 8,000, 11,000, and 14,000 options. These entries are shown as holdings rather than new option exercises or grants.

What role does Timothy J. Shelly hold at National Healthcare Corp in this Form 4?

Timothy J. Shelly is identified as Senior Vice President of Operations of National Healthcare Corp. His position is noted in the insider information section and explains why his equity compensation grant must be reported on Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shelly Timothy J.

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP Operations

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		1,294(1)	A	$0	1,294	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	2,400		2,400	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	11,000		11,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

	/s/ Timothy J. Shelly	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.